Board Judgment

The Clock That Can Decide Your Exit—and How Boards Take Back Control

Fund lifespans are finite. Company lifespans aren’t. When those timelines diverge, boards can face pressure toward premature exits. Here’s how to preserve exit optionality, separate liquidity from control, and keep one investor’s clock from deciding the company’s future.

By Tom Krutilek
July 29, 2026

The Clock That Can Decide Your Exit—and How Boards Take Back Control

Fund lifespans are finite. Company lifespans aren’t. Two decades of research show what happens when those timelines diverge—and what boards can do before the clock runs down.

In brief

  • Two decades of peer-reviewed research show that as an investor’s fund ages, its portfolio companies face higher odds of being acquired or shut down—and achieving operating milestones does not eliminate the added risk.
  • Venture capital has concentrated sharply, leaving many founders across the table from smaller funds facing increasing pressure to return capital, while a small group of firms with fresh capital can afford to wait.
  • Liquidity no longer always requires a sale. Boards that design liquidity deliberately and include genuinely independent directors can reduce the pressure that leads to premature exits.

Somewhere right now, a board and a founder are having a version of the same conversation.

An investor-appointed director wants an exit. A clean one — de-risked, defensible, a return the fund can show its own investors. The founder wants to keep building. On the surface, it looks like a disagreement about timing, or ambition, or nerve.

It usually isn't. Neither side is confused, and neither is naive. What's colliding is a financial clock and an operating roadmap — and the research on what happens next should give every board pause.

A study in the Strategic Management Journal examined what happens to companies as their venture investors' funds age. It found that exit pressure from an aging fund did not increase the likelihood of an IPO. It significantly increased the likelihood of two other outcomes: being acquired and being liquidated. Two studies in the Journal of Financial and Quantitative Analysis fill in the picture. Companies backed by funds nearing the end of their lives were acquired at lower prices relative to their book value. And aging funds became measurably more likely to walk away from viable companies — not just failing ones.

Then there’s the finding that should stop every founder and CEO cold: achieving operating milestones did not reduce the added risk created by an aging fund. Hitting your numbers did not protect the company from pressure toward a low-value sale or shutdown. Performing well helps. It does not make you safe.

A company can hit its milestones and still be pushed toward an early exit.

This isn’t a story about bad investors. It’s a story about how investment funds are structured. The argument in that boardroom is not really about the company’s future. It’s about a fund’s clock—and for twenty years, that clock has too often won.

Why the clock exists

The mechanism can be stated in one sentence: funds have finite lives, and companies don't.

A venture or private equity fund is typically created with a ten-year horizon, sometimes with the possibility of extensions. It must eventually return cash—not unrealized paper valuations, but cash—to the investors who funded it, because those investors have obligations and expectations of their own. A great company, meanwhile, may need fifteen years to reach its full value. When those timelines diverge, one eventually gives way. The research shows which one too often prevails. 

What has changed is that liquidity pressure has intensified while capital has become increasingly concentrated. As of June 30, 2026, roughly 13,500 US companies remained in private-equity portfolios—an inventory that would take approximately nine years to clear at the recent pace of exits. Funds expected to return cash to their investors are holding companies that they have been unable to sell.

At the same time, capital has pooled at the top. In the first half of 2026, US venture deal value reached $412.7 billion, with rounds of $100 million or more accounting for 87.5% of the total. Concentration was equally pronounced in fund formation: Andreessen Horowitz, Thrive Capital, and Founders Fund collectively raised $34.8 billion—48.1% of all US venture capital raised during the period. First-time fund formation, meanwhile, is on pace for its weakest year since 2016, according to PitchBook.

Read that from the founder’s chair. Far fewer new funds are forming, while an increasing share of capital is flowing to a small group of large firms. The investors on many cap tables are therefore not the giants with fresh capital and the patience it buys. They are smaller funds still holding 2019–2021 vintage investments, with limited partners waiting for distributions and the fund’s clock running.

Capital concentration gave the largest funds more time to wait—while smaller funds faced greater pressure to seek exits.

What changed: liquidity no longer always requires a sale

This is where the board’s options have expanded.

For most of the modern era, an “exit” bundled three separate decisions together: what happens to the company, who owns it afterward, and when shareholders receive liquidity. The one word, “exit,” covered all three. Now, those decisions are increasingly being separated—and shareholder liquidity no longer always depends on selling the company.

The shift is clear: shareholders are increasingly receiving liquidity without the company being sold. In the secondary market, existing shareholders sell private shares to new buyers while the business remains independent. PitchBook estimated that US venture-secondary activity reached an annualized $112.2 billion in early 2026, exceeding the comparable value of US venture-backed public listings for the first time. Company-sponsored tender offers have also become more common, allowing eligible employees and early investors to sell shares at a set price during a defined period.

This isn't a venture-world quirk. Facing that nine-year backlog, private equity firms stopped waiting too. Rather than sell businesses, they've pulled cash out of them — borrowing against healthy companies and paying the proceeds out, or selling minority stakes while keeping control. 

The business can keep building while shareholders get liquidity—without selling the company.

The same separation can work in reverse, too. When SpaceX agreed in June 2026 to acquire Anysphere—the company behind Cursor—for $60 billion, it announced an all-stock transaction. Founders, employees, and investors would receive SpaceX shares rather than cash. At that scale, an all-stock deal is not unusual—and that is precisely the point. Even one of the largest startup acquisitions ever announced separates selling the company from receiving immediate liquidity.

For some companies, the clock problem now has a conditional answer. If the boardroom conflict is really about when shareholders receive liquidity, that need may be addressed without sacrificing the company’s independence or forcing a premature sale.

But these tools are instruments, not escape hatches. A secondary program requires real buyer demand, and many private companies don't have it at any credible price. Tender offers raise questions about who may sell, how much they may sell, and at what valuation. A dividend recapitalization—in which the company borrows money and distributes some of the proceeds to shareholders—doesn’t make the clock disappear. It moves the pressure onto the company’s balance sheet. 

Every one of these carries tax, securities law, consent, signaling, and fairness considerations. They work when they're designed. They backfire when they're improvised.

These liquidity tools can relieve pressure, but choosing among them is not the board’s starting point. The board must first understand whose timelines are driving the pressure, which strategic paths are genuinely available, and what the company must build to preserve those choices. That is the purpose of “exit optionality”.

Exit optionality: three questions

Exit optionality does not mean keeping every door open—that is expensive and unfocused. It means maintaining a small number of paths that a buyer, banker, or investor would genuinely underwrite, and being ready to move when one opens.

The analysis begins with three questions, worked in order.

First: whose clock is running? Where is each investor in its fund’s lifecycle? A fund in year two can usually wait. A fund in year eight may be under real pressure—and research suggests that pressure can influence company outcomes whether or not anyone names it.

But investors are not the only ones with clocks. Employees face option expirations, tax exposure, and personal financial needs. Founders may have substantial wealth concentrated in one company. The business may have debt maturities, and markets themselves have windows.

Map them all.

Second: which doors are actually open to you? “The market is open” and “the market is open for my company” are different statements. The IPO window reopened in 2026, but it continues to reward scale. Twelve US IPOs each raised more than $1 billion in the first half of the year, up from four a year earlier, led by AI infrastructure, aerospace and defense, and biotech.

Other paths have their own requirements. Strategic acquirers want capabilities they cannot build quickly enough themselves. Private equity buyers want durable cash flow. Secondary liquidity requires real buyer demand.

The goal is not to list every theoretical option. It is to identify the two or three paths the market would genuinely support for your company today.

Third: what must you become for each path? Each route demands different proof:

  • IPO: a durability story—predictable reporting, audited financials, public-company controls, and an equity narrative that can withstand quarterly scrutiny.
  • Strategic acquisition: a scarcity story—clean intellectual property and a capability someone will pay a premium to own rather than spend several years building.
  • Private equity: a cash-flow story—margins, borrowing capacity, and a credible value-creation plan.
  • Secondary liquidity: a demand story—buyers willing to purchase the company’s shares at a defensible price.

None of this can be assembled in the ninety days before a term sheet arrives.

Putting the framework to work

The three questions matter only if they become a board discipline rather than a one-time discussion. Boards should conduct a standing exit-optionality review at least annually—and whenever a significant financing decision, unsolicited offer, or change in investor circumstances reopens the issue.

The review should produce three written answers:

  • Whose clocks are running? A map of fund vintages and remaining fund lives, employee option expirations and tax exposure, founder concentration, debt maturities, and relevant market windows.
  • Which doors are genuinely open? Two or three credible paths, each supported by actual buyer, banker, investor, or market evidence—not aspiration.
  • What must we become? The common readiness capabilities that strengthen every path, together with the specific proof required for each credible option.

The board should then make two implementation decisions:

  • Can liquidity be separated from control? Determine whether a tender offer, a structured sale of existing shares, a minority recapitalization, or a dividend recapitalization could address the pressure without requiring a sale of the company—or conclude that no action is appropriate and document why.
  • When will the board revisit the analysis? Name an owner, establish the events that would reopen the discussion, and set the next review date.

A board that documents these three answers and two implementation decisions each year is far less likely to be surprised—or forced—by its eventual exit. Two moves make that discipline real.

Put genuinely independent directors in the room. This is the most actionable finding in the research: independent directors moderated the effect of fund-age exit pressure — increasing the likelihood of a high-value sale and reducing the likelihood of liquidation. 

The word doing the work is genuinely. A director recruited by, and beholden to, an investor with a running clock is not the circuit-breaker the research describes. You need someone in the room whose incentives are tied to the company's timeline rather than a fund's.

And a related discipline: investor-appointed directors do not simply represent the liquidity interests of the fund that nominated them. Their fiduciary obligations generally run to the corporation and its shareholders as a whole, subject to applicable law and the company’s governing documents. Recognizing an investor’s liquidity pressure does not mean allowing that pressure to control the board’s decision.

Design liquidity instead of waiting for it. That boardroom fight—one clock demanding an exit, another demanding patience—is, more often than it looks, a liquidity problem wearing an exit costume. A deliberate tender offer, a minority recapitalization—in which a new investor provides liquidity while existing owners retain control—or a structured sale of existing shares can relieve pressure that might otherwise force a premature sale. These mechanisms can provide liquidity to the people a sale was meant to pay while giving the company more time to reach the opportunity worth pursuing. 

The best boards treat liquidity as an instrument—not a finish line.

The board's real job

The research has been consistent for two decades: when a fund's clock runs down, companies are sold earlier, sold at lower valuations, or shut down — and performing well does not make them safe.

What's new is that boards aren't helpless against it. Some capabilities strengthen every path at once—a clean cap table, audited numbers, real governance, and a narrative that holds up. Each specific path still demands its own proof. And the liquidity that once required selling the company can now, for a growing set of companies, be built without it.

The best exit strategy was never a prediction about a single transaction. It's a short list of credible paths, the readiness to choose when the moment arrives, and the discipline to engineer liquidity in the meantime — so that no one's clock gets to decide for you.

Exit optionality isn't timed. It's built. And increasingly, so is liquidity.

Summary

Fund lifecycles and company lifecycles do not always align, and that mismatch can push viable businesses toward premature exits. Boards can reduce the risk by mapping the clocks, maintaining two or three credible strategic paths, and building the evidence each path requires. Where market demand and company circumstances allow, liquidity tools may address investor needs without forcing a sale. The objective is to preserve credible choices so that the company’s strategy—not one investor’s deadline—determines the outcome.

References

#ExitStrategy #BoardGovernance #VentureCapital #PrivateEquity #Liquidity

About the Author

Tom Krutilek is a Board Advisor and Chief Marketing Officer who works with early-stage and growth-stage companies on capital readiness, investor narrative, go-to-market strategy, and AI strategy and governance. His work focuses on a central question: whether growth is truly investable—not just impressive on paper.

He helps founders, CEOs, and boards connect commercial performance, capital strategy, and execution to the evidence investors need to underwrite growth. That includes strengthening the investor narrative, identifying gaps in capital readiness, building measurable growth systems, and evaluating where AI can create durable business value and competitive advantage.

Tom is also the founder of The Investor Narrative, a publication focused on private capital markets from the perspective of investor readiness. It examines the questions behind the headline numbers—how investors assess growth, capital efficiency, demand quality, competitive advantage, governance, and the assumptions that ultimately determine whether a company is ready for investment capital.

Connect with Tom on LinkedIn

Topics: Board Judgment